Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Discover Momenta Ltd
| Project | Scaling a promising Cardiovascular Disease Prevention Programme (CPP) |
|---|---|
| Description |
Momenta’s market-leading Cardiovascular Disease prevention programme (CPP) has been co-developed with the South Eastern Trust in Northern Ireland with input from the British Heart Foundation. The project is a multi-partner, cross-sector, multi-clinician collaboration and demonstration project to optimise scalability across three care pathways in Birmingham and Solihull, enabling rapid subsequent national dissemination. |
| Funding | £ 491,214 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | West Midlands AHSN |
| Website | https://discovermomenta.com/ |
Huma
| Project | A digital first, population-level, early detection, engagement and self-management programme for people who are undiagnosed and/or high-risk of developing modifiable Cardiovascular Disease (CVD) |
|---|---|
| Description |
Huma’s remote patient monitoring (RPM) platform connects patients and clinical teams through smartphone-based technology. Huma’s primary care arm – iPlato – are experts in enhancing patient access and engagement through technology. For this project, Huma and iPlato’s technologies will proactively engage and support people who are identified by their GPs as being high-risk of undiagnosed CVD. |
| Funding | £ 493,877 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | UCLPartners AHSN |
| Website | https://www.huma.com |
Cardisio GmbH
| Project | Assessing the impact of using community-based heart testing to detect early signs of Cardiovascular Disease through a novel, quick, low-cost screener which uses sophisticated AI-based analysis |
|---|---|
| Description |
The Cardisio test is a quick 1st line triage test, measuring a patient’s electrical heart activity in 3-dimensions, and is taken at rest in a primary care setting. Test results in 3 disease areas (CAD, arrythmia, Structural heart disease) are made available to the physician in c.4 minutes. |
| Funding | £ 342,484 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | Eastern AHSN |
| Website | https://www.cardis.io |